LKT Labs, Not dangerous goods, 868540-17-4
1 - 1 of 1
Sort
View
Show
-
Carfilzomib
LKT LabsCarfilzomib is an analog of epoxomicin that functions as a proteasome inhibitor. This drug has been approved for use in humans with multiple myeloma. Carfilzomib binds irreversibly to the 20S proteasome, which exhibits chymotrypsin-like activity and is responsible for degradation of cellular…
Site Search by